Stock Performance and Market Context
On 24 Nov 2025, Tarsons Products recorded an intraday low of Rs.198.7, representing a drop of 9.12% during the trading session. This level also stands as the company’s all-time low price. The stock has been on a consecutive decline for 16 trading days, resulting in a cumulative return of -28.35% over this period. This performance contrasts sharply with the broader market, as the Sensex opened higher by 88.12 points and was trading at 85,343.57, up 0.13% on the day. The Sensex is currently within 0.54% of its 52-week high of 85,801.70 and has recorded a 2.56% gain over the past three weeks, supported by strong performances from mega-cap stocks.
Tarsons Products has underperformed its sector by 4.95% on the day, with the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The intraday volatility was measured at 5.92%, indicating heightened price fluctuations during the session.
Long-Term Performance and Valuation Metrics
Over the last year, Tarsons Products has generated a return of -46.48%, significantly lagging behind the Sensex’s 7.85% gain during the same period. The stock’s 52-week high was Rs.465, highlighting the extent of the decline to the current low. This underperformance extends beyond the past year, with the stock consistently trailing the BSE500 benchmark in each of the last three annual periods.
Financially, the company’s operating profit has shown a negative compound annual growth rate of approximately -18.84% over the past five years. The latest quarterly results for September 2025 reveal a PAT of Rs.3.32 crores, which is down by 51.8% compared to the average of the previous four quarters. The return on capital employed (ROCE) for the half-year period stands at 6.69%, one of the lowest levels recorded recently. Meanwhile, the debt-to-equity ratio has risen to 0.41 times, marking the highest level in the company’s recent history.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Institutional Holding and Market Participation
Institutional investors have reduced their stake in Tarsons Products by 3.27% over the previous quarter, now collectively holding 5.91% of the company’s shares. This decline in institutional participation may reflect a shift in market assessment regarding the company’s fundamentals. Institutional investors typically possess greater resources and analytical capabilities to evaluate company performance, and their reduced involvement is notable in the context of the stock’s recent trajectory.
Debt Servicing and Valuation Considerations
Despite the challenges reflected in profitability and share price, Tarsons Products maintains a relatively strong ability to service its debt obligations. The average EBIT to interest ratio is 12.03, indicating that earnings before interest and tax comfortably cover interest expenses. The company’s ROCE of 3.9 and an enterprise value to capital employed ratio of 1.5 suggest a valuation that is fair relative to its capital base. Furthermore, the stock is trading at a discount compared to the historical average valuations of its peers within the Healthcare Services sector.
Profitability has also been under pressure, with profits falling by approximately 30% over the past year. This decline in earnings aligns with the broader trend of subdued financial performance and has contributed to the stock’s downward movement.
Holding Tarsons Products from Healthcare Services? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Market Indicators
Tarsons Products’ current market capitalisation grade is rated at 3, reflecting its mid-tier market value within the sector. The stock’s day change of -4.25% on 24 Nov 2025 further emphasises the ongoing pressure on the share price. The company’s stock price remains well below all major moving averages, signalling a sustained bearish trend in technical terms.
In contrast, the broader market environment remains relatively positive. The Sensex is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a bullish trend for the benchmark index. This divergence between Tarsons Products and the overall market highlights the company’s specific challenges amid a generally favourable market backdrop.
Conclusion
Tarsons Products’ fall to a 52-week low of Rs.198.7 marks a significant milestone in a prolonged period of share price decline. The stock’s performance over the past year and recent quarters reflects subdued profitability, increased leverage, and diminished institutional interest. While the company maintains a reasonable capacity to service debt and trades at a valuation discount relative to peers, the prevailing market data points to ongoing headwinds. The stock’s position below all key moving averages and its extended losing streak underscore the challenges faced by Tarsons Products within the Healthcare Services sector.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
